Search

everythinglearnresearchcommunity

for

Search:↓

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.

Radiation therapy is an effective treatment for severe scalp cellulitis with mild side effects and no long-term complications.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Penguin Cold Caps help most patients keep at least half their hair during chemotherapy.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.